[go: up one dir, main page]

Agnes et al., 2025 - Google Patents

Radiomic-based models are able to predict the pathologic response to different neoadjuvant chemotherapy regimens in patients with gastric and gastroesophageal …

Agnes et al., 2025

View HTML @Full View
Document ID
1527386199167181935
Author
Agnes A
Boldrini L
Perillo F
Tran H
Brizi M
Ricci R
Lenkowicz J
Votta C
Biondi A
Manfredi R
Valentini V
D’Ugo D
Persiani R
Publication year
Publication venue
World Journal of Surgical Oncology

External Links

Snippet

Background There is a clinical need to identify early predictors for response to neoadjuvant chemotherapy (NAC) in patients with gastric and gastroesophageal junction cancer (GC and GEJC). Radiomics involves extracting quantitative features from medical images. This study …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/24—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for machine learning, data mining or biostatistics, e.g. pattern finding, knowledge discovery, rule extraction, correlation, clustering or classification
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/20—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for hybridisation or gene expression, e.g. microarrays, sequencing by hybridisation, normalisation, profiling, noise correction models, expression ratio estimation, probe design or probe optimisation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Similar Documents

Publication Publication Date Title
Huang et al. Criteria for the translation of radiomics into clinically useful tests
Cusumano et al. Fractal-based radiomic approach to predict complete pathological response after chemo-radiotherapy in rectal cancer
Marti-Bonmati et al. Pancreatic cancer, radiomics and artificial intelligence
Mani et al. Machine learning for predicting the response of breast cancer to neoadjuvant chemotherapy
Zhong et al. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning
Yen et al. Effect of hospital volume on processes of breast cancer care: a National Cancer Data Base study
Marti-Bonmati et al. Considerations for artificial intelligence clinical impact in oncologic imaging: an AI4HI position paper
Ni et al. Machine-learning and radiomics-based preoperative prediction of Ki-67 expression in glioma using MRI data
Ding et al. A deep learning nomogram kit for predicting metastatic lymph nodes in rectal cancer
Boldrini et al. Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort
Le Vuong et al. Prediction of Epstein-Barr virus status in gastric cancer biopsy specimens using a deep learning algorithm
Yang et al. A predictive nomogram for lymph node metastasis of incidental gallbladder cancer: a SEER population-based study
Xu et al. Incidence and prognosis of distant metastasis in malignant peripheral nerve sheath tumors
Yan et al. CT-based radiomics nomogram for prediction of progression-free survival in locoregionally advanced nasopharyngeal carcinoma
Chitalia et al. Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer
Chang et al. Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy
Xv et al. Interpretable CT Radiomics-based machine learning model for preoperative prediction of Ki-67 expression in clear cell renal cell carcinoma
Lama et al. AI for BPH surgical Decision-Making: cost effectiveness and outcomes
Qu et al. An unsupervised learning model based on CT radiomics features accurately predicts axillary lymph node metastasis in breast cancer patients: diagnostic study
Liu et al. MRI-based radiomics feature combined with tumor markers to predict TN staging of rectal cancer
Dai et al. Ultrasound-based artificial intelligence model for prediction of Ki-67 proliferation index in soft tissue tumors
Spielvogel et al. Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga] Ga-PSMA-11 PET/MRI
Fujiwara et al. Preoperative diagnoses and identification rates of unexpected gallbladder cancer
Auguste et al. Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study
Agnes et al. Radiomic-based models are able to predict the pathologic response to different neoadjuvant chemotherapy regimens in patients with gastric and gastroesophageal cancer: a cohort study